首页> 外文期刊>Journal of drug targeting >Preparation of vincristine sulfate-loaded poly (butylcyanoacrylate) nanoparticles modified with pluronic F127 and evaluation of their lymphatic tissue targeting
【24h】

Preparation of vincristine sulfate-loaded poly (butylcyanoacrylate) nanoparticles modified with pluronic F127 and evaluation of their lymphatic tissue targeting

机译:普卢尼克F127修饰的硫酸长春新碱负载的聚(氰基丙烯酸丁酯)纳米颗粒的制备及对淋巴组织靶向性的评价

获取原文
获取原文并翻译 | 示例
           

摘要

In order to improve the lymphatic targeting efficiency of anti-cancer agent vincristine sulfate (VCR), the poly (butylcyanoacrylate) nanoparticles (VCR-PBCA-NPs) were prepared by emulsion polymerization and modified superficially with Pluronic F127. These prepared nanoparticles with (F127-VCR-PBCA-NPs) and without surface modification (VCR-PBCA-NPs) were characterized and their lymphatic targeting efficiencies were evaluated in vitro and in vivo. The results showed that VCR was released more sustained from both kinds of VCR-loaded nanoparticles, compared with the VCR solution. The up-taking efficiency of VCR into raji cells was enhanced by F127-VCR-PBCA-NPs, compared with the VCR-PBCA-NPs or VCR solution. Lower clearance (CL) of VCR from the systemic circulation and higher lymphatic targeting efficiency of VCR were observed for F127-VCR-PBCA-NPs than the VCR-PBCA-NPs or VCR solution, and F127-VCR-PBCANPs showed greater antitumor efficacy than the VCR-PBCA-NPs or VCR solution in the human Burkitt's lymphoma (raji)-bearing nude mice. These findings suggest that superficially modified nanoscale carriers might be promising vehicles for chemotherapeutic agents in the treatments of metastatic tumors and malignant lymphoma.
机译:为了提高抗癌剂硫酸长春新碱(VCR)的淋巴靶向效率,通过乳液聚合制备了聚(氰基丙烯酸丁酯)纳米颗粒(VCR-PBCA-NPs),并用Pluronic F127表面改性。对这些制备的具有(F127-VCR-PBCA-NPs)和没有表面修饰(VCR-PBCA-NPs)的纳米颗粒进行了表征,并在体外和体内评估了它们的淋巴靶向效率。结果表明,与VCR溶液相比,两种加载VCR的纳米颗粒均能更持久地释放VCR。与VCR-PBCA-NP或VCR解决方案相比,F127-VCR-PBCA-NP增强了VCR进入raji细胞的吸收效率。与FCR-PBCA-NP或VCR溶液相比,F127-VCR-PBCA-NP的VCR从全身循环中的清除率(CL)较低,VCR的淋巴靶向效率更高,F127-VCR-PBCANPs的抗肿瘤功效比VCR-PBCA-NPs或VCR溶液高。 VCR-PBCA-NPs或VCR溶液在人类伯基特氏淋巴瘤(raji)裸鼠中进行。这些发现表明,表面修饰的纳米级载体可能是用于治疗转移性肿瘤和恶性淋巴瘤的化学治疗剂的载体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号